Phase III APeX-2 trial of BCX-7353 to prevent HAE attacks meets primary endpoint May 21, 2019 No Comments
Achillion presents interim data from phase II trial of ACH-4471 with eculizumab in PNH May 17, 2019 No Comments
Enrollment open in phase III study of fostamatinib in warm antibody autoimmune hemolytic anemia May 17, 2019 No Comments
Sevuparin fails to show meaningful benefit in phase II trial to manage VOC in sickle cell disease May 14, 2019 No Comments
Pooled safety analyses of global roxadustat phase III program confirm CV safety May 10, 2019 No Comments
RSS